Crohn S Disease — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for crohn s disease. 71 active patents protecting 5 drugs from 3+ originators. First major cliff: 2027. Daily refresh.

5
Approved drugs
71
Active US patents
67/100
Avg vulnerability
$5.6B
Annual revenue covered

Originators in Crohn S Disease

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

AstraZeneca K.K. 37 patents Generic (originally Schering) 33 patents Padagis Us 1 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating crohn s disease. Each bar = one year. Y-axis scaled to peak year (10 patents).

6
26
6
27
4
28
3
29
10
30
6
31
5
32
4
33
7
34
5
36
3
37
2
38
3
39
1
41

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Pulmicort Respules
BUDESONIDE
 AstraZeneca K.K. 37 68 $2.8B 2026-11-09
Decadron
dexamethasone
 Generic (originally Merck) 15 46 — 2027-12-19
Cortef
hydrocortisone
 Generic (originally Merck/Upjohn) 14 64 — 2032-11-19
Deltasone
prednisone
 Generic (originally Schering) 4 76 — 2027-08-03
Verdeso
DESONIDE
 Padagis Us 1 80 $2.8B 2027-08-13

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
9119863 Pulmicort Respules method of use 93 2026-11-09
8975243 Pulmicort Respules method of use 93 2026-11-09
8497258 Pulmicort Respules method of use 93 2026-11-09
11357859 Pulmicort Respules method of use 88 2028-11-12
8491932 Pulmicort Respules method of use 83 2029-05-07
8324192 Pulmicort Respules method of use 81 2029-08-03
8460641 Verdeso method of use 80 2027-08-13
8168218 Deltasone method of use 80 2028-01-07
9415009 Pulmicort Respules method of use 76 2030-05-28
10716753 Pulmicort Respules method of use 76 2030-05-28

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10537585 Decadron formulation 25 2037-12-18
10159683 Decadron formulation 25 2034-05-23
10799642 Decadron formulation 31 2032-05-11
8409606 Decadron formulation 31 2030-05-14
8450287 Decadron formulation 38 2027-12-19
10022502 Decadron method of use 45 2034-06-22
10028965 Decadron method of use 45 2034-05-23
10307375 Pulmicort Respules formulation 48 2031-09-07
9132093 Pulmicort Respules formulation 48 2031-09-07
10660858 Pulmicort Respules formulation 48 2031-09-07

Related